FDA campaign H-0633-2026
Class IIIHazard
Packaging integrity issue that may compromise product quality .
Distribution
The product was distributed to the following states: NY, VA, FL, MA, TX, LA, UT, CA and Canada
REKALLD area-alert coverage: nationwide (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.